Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
drug
![Could Scientist Find Drug to Treat His Own Disease?](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Could-Scientist-Find-Drug-to-Treat-His-Own-Disease-400x400.jpeg)
Could Scientist Find Drug to Treat His Own Disease?
- By nasdaqpicks.com
- . 13 August 2023
How a researcher’s 12-year journey to a new Bristol-Myers psoriasis medicine became personal: “You have hopes and daydreams almost in some ways.” Source link
![Weight-Loss Drug Wegovy Cuts Heart Risk in New Study](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Weight-Loss-Drug-Wegovy-Cuts-Heart-Risk-in-New-Study-400x400.jpeg)
Weight-Loss Drug Wegovy Cuts Heart Risk in New Study
- By nasdaqpicks.com
- . 8 August 2023
Novo Nordisk’s anti-obesity drug reduced people’s risk of suffering heart attacks, strokes and cardiovascular deaths by 20%. Source link
![Drug Shortages Are a Boon to One Industry: Compounding Pharmacies](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Drug-Shortages-Are-a-Boon-to-One-Industry-Compounding-Pharmacies-400x400.jpeg)
Drug Shortages Are a Boon to One Industry: Compounding Pharmacies
- By nasdaqpicks.com
- . 7 August 2023
Hospitals increasingly rely on a sector that can start making drugs without FDA approval—and investment is pouring in. Source link
![Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Venture-Capitalist-Seeks-to-Spur-Drug-Development-for-Rare-Autoimmune-400x400.jpeg)
Venture Capitalist Seeks to Spur Drug Development for Rare Autoimmune Disease
- By nasdaqpicks.com
- . 1 August 2023
Venture capitalist Luke Evnin has financed several successful biotechnology startups that develop treatments for cancer. Now he is encouraging drugmakers to tackle another disease: a rare autoimmune condition that
![Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall](http://www.nasdaqpicks.com/wp-content/uploads/2023/08/Pfizer-Misses-Revenue-Expectations-Bets-on-Drug-Launches-to-Ease-400x400.jpeg)
Pfizer Misses Revenue Expectations, Bets on Drug Launches to Ease Shortfall
- By nasdaqpicks.com
- . 1 August 2023
The company is rolling out 19 products or new uses within 18 months, CEO Albert Bourla said. Source link
![Cannabis Industry Confronts Billion-Dollar Threat: Weak Weed](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Cannabis-Industry-Confronts-Billion-Dollar-Threat-Weak-Weed-400x400.jpeg)
Cannabis Industry Confronts Billion-Dollar Threat: Weak Weed
- By nasdaqpicks.com
- . 30 July 2023
A pathogen spreading among crops is cutting the recreational drug’s potency, forcing growers to cull “dudded” plants. Source link
![Hedge Funds Seek to Cut Off $1 Billion Meant for Opioid Victims](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/Hedge-Funds-Seek-to-Cut-Off-1-Billion-Meant-for-400x400.jpeg)
Hedge Funds Seek to Cut Off $1 Billion Meant for Opioid Victims
- By nasdaqpicks.com
- . 26 July 2023
Drugmaker Mallinckrodt is talking to hedge funds about filing for bankruptcy and avoiding payments intended to help people addicted to opioids. Source link
![How U.S. Drug Companies Could Tip Europe Into Recession](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/How-US-Drug-Companies-Could-Tip-Europe-Into-Recession-400x400.jpeg)
How U.S. Drug Companies Could Tip Europe Into Recession
- By nasdaqpicks.com
- . 23 July 2023
Swings in Ireland’s pharmaceutical industry, often rooted in tax moves by U.S.-based firms, have outsize impact on European output. Source link
![FDA Approves First RSV Drug to Protect All Infants](http://www.nasdaqpicks.com/wp-content/uploads/2023/07/FDA-Approves-First-RSV-Drug-to-Protect-All-Infants-400x400.jpeg)
FDA Approves First RSV Drug to Protect All Infants
- By nasdaqpicks.com
- . 17 July 2023
While the virus often leads to mild, coldlike symptoms, it is the leading cause of hospitalization of infants in the U.S. Source link
![U.S. Supreme Court turns away challenge to Trump's tariffs on steel imports By Reuters](http://www.nasdaqpicks.com/wp-content/uploads/2023/03/US-Supreme-Court-turns-away-challenge-to-Trumps-tariffs-on-400x400.jpg)
Acumen’s Alzheimer’s drug passes initial safety test By Reuters
- By nasdaqpicks.com
- . 16 July 2023
© Reuters. FILE PHOTO: Dr. Seth Gale points out evidence of Alzheimer’s disease on PET scans at the Center for Alzheimer Research and Treatment (CART)